Having trouble viewing this email? View it in your browser.
Musella Foundation Logo and Name of Email Blast
Wednesday, November 18, 2020
Issue 5790
Donations

Advocacy
Alert
The most important bill ever introduced into congress for brain tumor patients needs your support!
Click for details and to easily send letters.

Latest News

  • xCures launches xACCESS - A new module in their AI-assisted clinical platform         Through a collaboration with Cancer Commons and xCures, the Musella Foundation is proud to offer our patients free access to this system. View the press release and watch the video to see how the program works.  This module is what powers our "A Patient-Centric Platform Trial for Precision Oncology"  NCT03793088.    This program will evaluate you and help find the best treatment options for your specific case. We then try to help you get access to them if needed. Then we follow up to see what treatments you do and the outcome so we learn from every patient.  To get started, go to Virtualtrials.org and click on FIND TREATMENTS then on FULL SERVICE.   The Musella Foundation is focused on Brain Tumors, but Cancer Commons  also handles these tumor types: Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer, Melanoma, Non Small Cell Lung Cancer, Thyroid Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Esophageal Cancer, Cholangiocarcinoma, Ovarian Cancer, and Hepatocellular Carcinoma. It also handles any type of cancer that has one of these specific mutations: MAPK, KRAS, BRAF, NRAS, HRAS, MEK and ERK. For details go to Cancer Commons.Org   Disclaimer: Al Musella owns stock in xCures.

     



Sponsored By
Cedars-Sinai Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details

To view past stories go to : https://virtualtrials.org/newsblast.cfm
To submit a story/press release go to: click here To unsubscribe, click here.
The article commentaries are the opinions of Al Musella, DPM and do not represent the official position of the Musella Foundation. Copyright 1992-2020 Musella Foundation - All rights reserved. No part of the Brain Tumor News Blast can be reproduced without the express written permission of the Musella Foundation.